Jason Rocha, MD
Orthopaedic Trauma · Pensacola, FLNPI 1851542427
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,250 of the $23,633 with a category attached, or 73.0%. Arthrex accounts for 83.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $11,738 and has fallen 95.3% since, to $553 in 2025.
Across 77 payments — averaging $306.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Smith+Nephew$2K
- Johnson & Johnson$721
- CGG Medical Inc$519
- Amgen$138
- Radius Health, Inc.$123
- plus $282 from 9 others
What the payments were for
- Speaking & faculty fees$17,25073%
- Travel & lodging$2,81712%
- Food & beverage$2,26510%
- Education$1,3026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 25 | $19,659 |
| Smith+Nephew | 10 | $2,190 |
| Johnson & Johnson | 14 | $721 |
| CGG Medical Inc | 4 | $519 |
| Amgen | 4 | $138 |
| Radius Health, Inc. | 6 | $123 |
| DJO, LLC | 4 | $98 |
| Si-bone, Inc. | 3 | $67 |
| Olympus America Inc. | 1 | $21 |
| Orthofix Medical, Inc. | 1 | $20 |
| Bioventus LLC | 1 | $19 |
| Zimmer Biomet | 1 | $17 |
| Vericel Corporation | 1 | $16 |
| Pacira Therapeutics, Inc. | 1 | $13 |
| Integra Lifesciences Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,633 in reported general payments places this provider in the 55th percentile of 65 orthopaedic trauma providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 72 | $719 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $554 |
| Ondansetron OdtOndansetron | 40 | $459 |
| Gabapentin | 79 | $347 |
| Naproxen | 26 | $118 |
| Amoxicillin | 15 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Pensacola
- Leslie Barnes-RemskiPensacola$1K
- J Dean ColeOrlando$4.2M
- Vuong NguyenOrlando$1.4M
- Edward PerezFt Lauderdale$981K
- Hassan MirTemple Terrace$877K
- Daniel SeginaMelbourne$330K
- Kenneth KovalOrlando$321K
- Mohamed ShaathOrlando$303K
- Daniel DziadoszSt Petersburg$262K
- Frank AviluceaOrlando$191K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.